OptimizeRx Corp (OPRX) stock: key figures, P/E, revenue and dividend
Industrials · United States · ISIN US68401U2042
OptimizeRx Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 109.43 m USD |
| Gross profit | 73.60 m USD |
| Operating income | 11.69 m USD |
| EBIT | 11.89 m USD |
| Net income | 5.13 m USD |
| Diluted EPS – continuing operations | 0.27 USD |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About OptimizeRx Corp
OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.
More stocks
- Niagen Bioscience, Inc. (NAGE)
- NRC Group ASA (NRC.OL)
- Fidelix Co. Ltd (032580.KQ)
- United Pharm (033270.KS)
- VINCE HOLDING CORP. (VNCE)
- Donga Geologic (028100.KS)
- AN2 Therapeutics, Inc. (ANTX)
- Pappajack Bhd (0242.KL)
- Umweltbank (UBK.DE)
- NeoVolta Inc. (NEOV)
- Samba Digital, SGPS, S.A. (ALSMB.LS)
- XChange TEC.INC (XHG)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.